Cassava Sciences Inc (SAVA)
2.36
+0.07
(+3.06%)
USD |
NASDAQ |
Dec 20, 16:00
2.34
-0.02
(-0.85%)
After-Hours: 20:00
Cassava Sciences Shareholders Equity (Quarterly): 166.64M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 17.14B |
| BridgeBio Pharma Inc | -1.230B |
| Seelos Therapeutics Inc | -28.13M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| EyePoint Pharmaceuticals Inc | 218.73M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 223.75M |
| Total Liabilities (Quarterly) | 57.11M |